The IPO Buzz: Anteris (AVR) Prices NASDAQ Uplist Deal at $6 – Below Reference Price – & Raises $88.8 Millionby Jan Paschal. Posted on December 12, 2024
"Australian transcatheter heart valve developer Anteris Technologies Global (AVR) priced its NASDAQ uplisting/public offering at $6.00 – below its $6.78 reference price – and sold 14.8 million shares – the number of shares in the prospectus – to raise $88.8 million on Thursday night, Dec. 12, 2024.
The $6.00 IPO price gave Anteris Technologies Global a market cap of $215.64 million. Anteris Technologies Global’s stock started trading at $6.00 – flat with its IPO price – on Friday, Dec. 13, 2024, on the NASDAQ. The public offering price of $6.00 is less than half the average price per share of $12.53 paid by existing shareholders.
The company, founded in 1999, is not profitable. Anteris reported a net loss of US$71.1 million on revenue of US$2.71 million for the 12 months that ended Sept. 30, 2024."
AVR Price at posting:
$10.54 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)